How many insider declarations has Bar-Shalev Amos filed?

Bar-Shalev Amos has filed 2 public insider declarations with SEC (Form 4).

What is Bar-Shalev Amos's role?

Bar-Shalev Amos's reported role is not specified by the regulator across the filings.

Which companies does Bar-Shalev Amos report trades for?

Bar-Shalev Amos reports trades for Protalix BioTherapeutics, Inc..

What is Bar-Shalev Amos's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 271€.

← Executives ★ Sign in to follow

BA

Bar-Shalev Amos

OFFICERM

·SEC (Form 4)

Protalix BioTherapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€271

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Bar-Shalev Amos. Director active across 1 company, notably Protalix BioTherapeutics, Inc.. Aggregated, 2 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €271. Activity tracked since 18 November 2025. The latest transaction was disclosed on 18 November 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Bar-Shalev Amos

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Protalix BioTherapeutics, Inc. (US)

申报2 总计

▼

Bar-Shalev Amos

Director高管2025年11月18日Protalix BioTherapeutics, Inc.

US$31419SEC ↗

168 股@ US$1.87100.0% 占其流量Common StockSEC:0001385113-25-000005:0

◆

Bar-Shalev Amos

Director高管2025年9月3日Protalix BioTherapeutics, Inc.

0SEC ↗

7,500 股Common StockSEC:0001415889-25-023702:0

2 条申报中的 2 条

InsidersTradesSigma

← Executives ★ Sign in to follow

BA

Bar-Shalev Amos

OFFICERM

·SEC (Form 4)

Protalix BioTherapeutics, Inc.

0

申报总数

0

公司

—

▲ 买入（0 笔）

€271

▼ 卖出（1 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

1

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

无可用的信号评分。

Browse the full record of transactions filed by Bar-Shalev Amos. Director active across 1 company, notably Protalix BioTherapeutics, Inc.. Aggregated, 2 reports have been logged. Split: 0 buy · 1 sell. Total volume traded: €271. Activity tracked since 18 November 2025. The latest transaction was disclosed on 18 November 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.